Alternative Therapy Sparks Hope for Patients with Lupus

Rituxan was developed by Biogen and Genentech, and it has been considered over the years as a top-shelf treatment in lupus with the aim to decrease steroid burdens. However, this treatment has only been considered for patients who have shown inadequate responses to conventional therapies for exacting immunosuppression. So, it isn't as widely used as it should be.